Tobramycin Tear Concentrations
NCT00695435
Completed
To evaluate the Tobramycin tear concentration values of TOBRADEX® Ophthalmic Suspension, Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension versus TOBREX® Ophthalmic Solution in normal volunteers.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/23/2010
Locations: Contact Alcon Call Center For Trial Locations, Fort Worth, Texas
Conditions: Dry Eye
Register for Updates
Randomized Controlled Trials of the Effects of Decadron on Swallowing, Airway, and Arthrodesis
NCT01065961
Unknown
Anterior cervical discectomy and fusion with or without decompression is a well-established surgical treatment for spine patients with the appropriate indications. Anterior approach involves some retraction that affect the midline structures of the anterior neck. Irritation and swelling may result, leading to postoperative dysphagia and the less common but critically important occurrence of postoperative airway compromise. Steroids given intraoperatively may reduce the incidence of these adverse... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/09/2010
Locations: Albany Medical Center, Albany, New York
Conditions: Swallowing
Register for Updates
A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT00474188
Terminated
To evaluate the safety and efficacy of lenalidomide (Revlimid ®) in combination with dexamethasone in subjects with relapsed or refractory diffuse large B-cell lymphoma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/27/2009
Locations: Palo Verde Hematology/Oncology, Ltd., Glendale, Arizona +23 locations
Conditions: Diffuse Large B-cell Lymphoma
Register for Updates
Comparison of Oral Dexamethasone Doses in Asthma Exacerbation
NCT00942201
Completed
Hypothesis: A 2-day course of oral dexamethasone is the superior option for the resolution of symptoms and prevention of relapse in the emergency department (ED) management of mild-moderate asthma exacerbations.
Gender:
ALL
Ages:
Between 2 years and 17 years
Trial Updated:
07/17/2009
Locations: Rady Children's Hospital, San Diego, California
Conditions: Asthma, Reactive Airway Disease
Register for Updates
Study to Compare the Pharmacokinetics of a Dexamethasone Iontophoretic Patch to a Dexamethasone Injection
NCT00895076
Unknown
The primary objectives are to evaluate the extent of systemic exposure and dexamethasone bioavailability following a single application of a dexamethasone iontophoretic transdermal patch in healthy volunteers. The secondary objectives are to evaluate the systemic and topical safety of the dexamethasone iontophoretic transdermal patch and of the dexamethasone intramuscular (IM) injection.
Gender:
ALL
Ages:
Between 18 years and 45 years
Trial Updated:
05/06/2009
Locations: Cetero Research, Fargo, North Dakota
Conditions: Lateral Epicondylitis (Tennis Elbow)
Register for Updates
Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma
NCT00438841
Unknown
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as cyclophosphamide and dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Thalidomide may stop the growth of cancer cells by blocking blood flow to the cancer. Giving bortezomib together with cyclophosphamide, dexamethasone, and thalidomide may kill more cancer cell... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/12/2009
Locations: Alta Bates Summit Comprehensive Cancer Center, Berkeley, California +9 locations
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Register for Updates
Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries
NCT00835965
Unknown
The combination of aprepitant and lower dose dexamethasone is superior to aprepitant alone with respect to the proportion of patients with a complete response (no vomiting and no use of rescue therapy) during 24 hours after the placement of last suture/staple.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/03/2009
Locations: Lankenau Hospital, Wynnewood, Pennsylvania
Conditions: Nausea, Vomiting
Register for Updates
A Clinical Study of Tobradex AF
NCT00473070
Completed
The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/28/2008
Locations: Pittsburgh, Pittsburgh, Pennsylvania
Conditions: Cataract
Register for Updates
A Study of Children With Refractory or Relapsed ALL
NCT00187083
Completed
The main purpose of this study is to find out which form of asparaginase (the native E. coli/Erwinia) or PEG-asparaginase) is more effective during induction treatment for children with acute lymphoblastic leukemia that has come back after treatment (relapsed) or is resistant to treatment (refractory)
Gender:
ALL
Ages:
18 years and below
Trial Updated:
06/03/2008
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee
Conditions: Acute Lymphoblastic Leukemia
Register for Updates
Large Cell Lymphoma Pilot Study III
NCT00187070
Completed
The main purpose of this study is to find out if it is feasible to deliver a multi-agent chemotherapy regimen which features a shorter, more intensive, immunophenotype-directed approach, and includes an intensification phase with hematopoietic stem cell support for children with large cell lymphoma
Gender:
ALL
Ages:
18 years and below
Trial Updated:
05/06/2008
Locations: St. Jude Children's Reaearch Hospital, Memphis, Tennessee
Conditions: Lymphoma, Large Cell, Lymphoma, Non-Hodgkin
Register for Updates
Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma
NCT00187122
Completed
The main purpose of this study is to determine if it is feasible to administer an intensified, multi-agent chemotherapy regimen for children with stage III and IV non-Hodgkin lymphoma and to find out what the toxicities are.
Gender:
ALL
Ages:
All
Trial Updated:
04/21/2008
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee
Conditions: Lymphoblastic Lymphoma
Register for Updates
The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis
NCT00119002
Completed
This study will compare a single dose of oral dexamethasone to placebo in a multicenter, randomized, double blind trial of infants aged 2 to 12 months with first-time bronchiolitis (defined as wheezing within 7 days of onset). This is given as additional therapy beyond any other routine therapy used at that center. No current standard therapy is withheld, and no additional tests or other treatments are part of the study.The primary hypothesis is that dexamethasone will be more effective than pla... Read More
Gender:
ALL
Ages:
Between 2 months and 11 months
Trial Updated:
03/13/2008
Locations: Primary Children's Medical Center, Salt Lake City, Utah
Conditions: Bronchiolitis, Viral
Register for Updates